Equine Multinodular Pulmonary Fibrosis in association with asinine herpesvirus type 5 and equine herpesvirus type 5: a case report
© Back et al.; licensee BioMed Central Ltd. 2012
Received: 23 April 2012
Accepted: 14 July 2012
Published: 25 September 2012
A standardbred gelding with a history of 10 days pyrexia and lethargy was referred to the Equine Hospital at the Swedish University of Agricultural Sciences in Uppsala, Sweden.
The horse had tachypnea with increased respiratory effort and was in thin body condition. Laboratory findings included leukocytosis, hyperfibrinogenemia and hypoxemia. Thoracic radiographs showed signs of pneumonia with a multifocal nodular pattern, which in combination with lung biopsy findings indicated Equine Multinodular Pulmonary Fibrosis (EMPF). EMPF is a recently described disease in adult horses with clinical signs of fever, weight loss and respiratory problems. The pathological findings include loss of functional pulmonary parenchyma due to extensive nodular interstitial fibrosis which has been related to infection with the equine herpesvirus type 5 (EHV-5). In this case, lung biopsy and tracheal wash samples tested positive for both asinine herpesvirus type 5 (AHV-5) and EHV-5 using PCR assays. The horse failed to respond to treatment and was euthanized for humane reasons. Postmortem examination confirmed the diagnosis of EMPF. This case suggests that not only EHV-5 alone should be considered in association with the development of this disease.
KeywordsHorse Equine Multinodular Pulmonary Fibrosis AHV-5 EHV-5 Lung
Equine herpesvirus type 5 (EHV-5) is one of the nine herpesviruses known to infect Equidae . The family Herpesviridae is divided into three subfamilies: Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae, where EHV-5 together with EHV-2 and EHV-7 (also called asinine herpes virus −2 ) are classified as equine gammaherpesviruses . EHV-5 was first isolated in the seventies from two horses in quarantine in Australia with clinical signs of upper respiratory tract disease . EHV-5 is recognized as a widespread finding in both nasal secretions and peripheral blood mononuclear cells of asymptomatic horses [4–7]. However, little is known about the potential role of EHV-5 causing clinically or subclinical infections associated with disease or poor performance in horses. One study has shown a higher prevalence of EHV-5 (as well as EHV-2) in horses with airway inflammation when compared to clinical healthy horses . The asinine herpesviruses (AHV) 4 and 5 are also classified as gammaherpesviruses and are closely related to the equine gammaherpesviruses . In horses AHV infection has only been described sporadically. Nonetheless, in a case–control study of horses with respiratory disorders or “poor performance syndrome” Fortier et al.  detected AHV-5 only in the clinical case group, which suggested that AHV-5 may play a clinically important role in horses.
There is also increasing evidence that EHV-5 may be associated with the occurrence of Equine Multinodular Pulmonary Fibrosis (EMPF), which was first described in 2007 as a disease in adult horses characterized by chronic, multifocal, fibrotic lung disease . The clinical presentation of EMPF includes pyrexia, weight loss and respiratory signs ranging from mild tachypnea to marked dyspnea. Thoracic radiographs reveal an interstitial-to-nodular pulmonary pattern  and the most consistent hematological changes are neutrophilia and hyperfibrinogenemia . Histological examination of lung tissue include multiple, well-demarcated nodular regions of pulmonary interstitial fibrosis with mixed inflammatory cell infiltration. Although the role of EHV-5 in EMPF is not fully determined, there is a strong circumstantial association of this virus with the pulmonary pathology presented in EMPF . Similarly it appears that the gammaherpesvirus Murine herpesvirus 68 (MHV68) may be a co-factor for the development of a comparable presentation of pulmonary fibrosis seen in mice .
EMPF and infection with EHV-5 has been reported in both the USA [11, 12, 15] and Europe [16–18]. Some of the horses diagnosed with EMPF appeared to be infected with both EHV-5 and EHV-2 but co-infection with EHV-2 has not been further investigated [11, 16, 17]. By comparison, AHV-4 and AHV-5 in association with EMPF have only been described by Kleiboeker et al. where a group of donkeys with respiratory disease at necropsy demonstrated changes associated with interstitial pneumonia . The present case report describes a standardbred gelding with clinical signs and lung pathology consistent with EMPF. What is striking in this case is the apparent co-infection with AHV-5 and EHV- 5. Both viruses were detected by PCR in samples from lung tissue and tracheal wash. While detection of AHV-5 in this horse with EMPF does not imply causation, its role as a pathogen in horses warrants further study, in particular as a co-factor with EHV-5 in the development of EMPF.
A 4-year-old standardbred gelding weighing approximately 560 kg, was referred to the Equine Hospital at the Swedish University of Agricultural Sciences in Uppsala. Prior to presentation there was a 10-day history of fever (38.5-40°C), unwillingness to move, intermittent tachypnea and mild cough. No nasal discharge had been noted. The horse had been treated with procaine penicillin intramuscularly and acetylcysteine orally with no improvement. The gelding had been with the current owner at the same farm for three years prior to presentation. There was no history of contact with donkeys. The owner has given consent for publication of this clinical case.
Physical examination and laboratory findings
On admission the horse was lethargic and tachypneic with shallow breathing. Clinical examination revealed a rectal temperature of 38.2°C, a heart rate of 48 beats per minute and a respiratory rate of 52 breaths per minute. The horse was in thin body condition and increased breathing sounds were present bilaterally over the thorax. Further diagnostic evaluation included venous and arterial blood sampling, endoscopy, chest radiography, ultrasound and finally percutaneous lung biopsy. On endoscopy there were multiple petechial hemorrhages generally distributed on the laryngeal mucosa and a mild accumulation of mucus in the trachea. A tracheal aspirate obtained via the endoscope was negative for bacterial growth under aerobic and anaerobic conditions. No cytology was performed on the tracheal aspirate.
Hematological and biochemical findings included: leukocytosis (17.7 x 109/L reference range 5.5-12), with a mature neutrophilia (10.8 x 109/L reference range 2–6.6), hyperfibrinogenemia (7.4 g/L reference range 1.8-4.2) and low serum creatinine (52 μmol/L reference range 88–145).
These findings suggested a systemic inflammatory process. The hypocreatinemia was likely related to the thin body condition and low muscle mass of the horse.
The arterial blood sample showed hypoxemia (Pao2 51.75 mmHg, A-a gradient 42).
Thoracic radiographs showed a generalized mixed interstitial and nodular pattern in the lung parenchyma, and ultrasonographic examination revealed a diffuse roughening of the pleural surface, without signs of free fluid in the thorax.
A transthoracic lung biopsy was performed, under ultrasound-guidance, using a BARD Magnuma on the right side of thorax following sedation with butorphanol (Butador®)b and detomidine i.v. (Cepesedan®)c and local anesthesia of the skin and deeper tissues at the biopsy site. Histological examination of the lung biopsy performed with hematoxylin and eosin (HE) staining demonstrated fibrosis with a widening of the interstitial space and presence of mature, intermittently hyalinated collagen. In the same area a mild to moderate infiltrate of inflammatory cells (mainly lymphocytes, a few macrophages and neutrophilic granulocytes) was present. Fibrosis was seen around smaller bronchioles and cuboidal cells lined alveoli. The epithelium of the bronchioles was intact and showed mild to moderate exocytosis. In alveoli and in some bronchioles a moderate to marked infiltrate of inflammatory cells mostly composed of degenerated neutrophils was observed. A histological diagnosis of chronic active interstitial fibrotic pneumonia was made.
No fungi were detected with periodic acid-shiff (PAS) staining and there was no bacterial growth obtained from culture of the biopsy under aerobic or anaerobic conditions.
According to a multi PCR analysis for respiratory viruses in horsesd, a sample from nasal swab was negative for Equine Influenza Virus, EHV-1, EHV-4, Equine Rhinitis B Virus and Equine Arteritis Virus.
Treatment and outcome
Initially the horse was treated with salbutamol (Ventoline®)e 0. 7 mg/kg administrated via Aeromaskf, and provided intranasal oxygen (15 L/min), dexamethasone (Dexadreson®)g 0. 1 mg/kg bwt i.v. q 24 h and penicillin (Geepenil®)h 27 167 IU/kg bwt i.v. q 8 h.
The horse did not respond to treatment and 3 days after admission started showing signs of severe dyspnea. Due to the clinical deterioration and the poor prognosis, the horse was humanely euthanized.
PCR and sequence analysis
This case report describes a horse with clinical signs and histological changes within the lung that correspond with the recently described disease EMPF  that has been associated with infection by EHV-5. What was noteworthy in this clinical case was that AHV-5 was also found along with EHV-5, making it unclear whether one, or both in concert were responsible for the pulmonary disease.
AHV-5 and EHV-5 are two separate viruses. As can be shown in the phylogenetic tree (Figure 3) there is a close relationship between the AHV-5 sequence from the present case with reference sequences for AHV-5 and the WAHV. Albeit based on short fragment of the genome the phylogeny show a distinct difference between AHV-5 and EHV-5 even though they both belong to the gammaherpesvirus subfamily.
Pulmonary interstitial fibrosis is an uncommon disease in horses and has often been described as being idiopathic in origin [23, 24]. In human medicine considerably more research has been conducted on the genesis of idiopathic pulmonary fibrosis (IPF) but the pathogenesis remains unclear. IPF may be related to epithelial cell injury, abnormal fibroproliferation, inflammation and deposition of extracellular matrix components. Several viruses, especially gammaherpesviruses, have been implicated as co-factors for initiating, promoting or exacerbating IPF [14, 25–27]. While these studies do not prove total causality, the association between gammaherpesviruses and IPF like conditions in horses, mice and human is striking.
To the authors´ knowledge, this is the first report of EMPF in Sweden and also the first report with AHV-5 in horses in association with EMPF. Previous studies on EMPF appear to have focused their investigations on EHV-1, EHV- 2, EHV-4 and EHV-5 thus the co- presence of the AHV in some of those cases may also have occurred. However, even if this report indicates an association, further studies with inclusion of age and breed-matched control horses are needed to define the possible role of AHV-5 in the pathogenesis in EMPF and a baseline prevalence study could give valuable information about the distribution and importance of this pathogen. Furthermore, the development of a quantitative PCR for EHV-5 and AHV-5 would be of benefit to evaluate if one of the pathogens is present in larger quantity at the site of the lesions, possibly indicating an active role in the pathogenesis.
In conclusion, it appears that not only EHV-5 but also other equine gammaherpesviruses should be considered when investigating the cause/s of EMPF.
The authors wish to thank prof. Sándor Belák and Dr. Jean-Francois Valarcher at the National Veterinary Institute, Uppsala, Sweden for critical review of the manuscript.
aBard Biopsy Systems, Tempe Arizona, USA.
bVetoquinol Scandinavia AB, Åstorp, Sweden.
cScanvet, Parola, Finland.
dNational Veterinary Institute, Uppsala, Sweden
eVentoline, GlaxoSmithKline AB, Solna, Sweden.
fTrudell Medical International, London, Ontario, Canada
gIntervet, Sollentuna, Sweden.
hOrion Pharma AB Animal Health, Sollentuna, Sweden.
- Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E: The order Herpesvirales. Arch Virol. 2009, 154: 171-177. 10.1007/s00705-008-0278-4.PubMed CentralView ArticlePubMed
- Fortier G, van Erck E, Pronost S, Lekeux P, Thiry E: Equine gammaherpesviruses Pathogenesis, epidemiology and diagnosis. Vet J. 2010, 186: 148-156. 10.1016/j.tvjl.2009.08.017.View ArticlePubMed
- Studdert MJ, Turner AJ, Peterson JE: Equine Herpesviruses. 1. Isolation and characterisation of equine rhinopneumonitis virus and other equine herpesviruses from horses. Aust Vet J. 1970, 46: 83-10.1111/j.1751-0813.1970.tb15927.x.View ArticlePubMed
- Kemeny L, Pearson JE: Isolation of herpesvirus from equine leukocytes. Comparision with equine rhinopneumonitis virus. Canadian Journal of Comparative Medicine. 1970, 34: 59-PubMed CentralPubMed
- Nordengrahn A, Merza M, Ros C, Lindholm A, Palfi V, Hannant D, Belak S: Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays. Vet Res. 2002, 33: 251-259. 10.1051/vetres:2002013.View ArticlePubMed
- Bell SA, Balasuriya UBR, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ: Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Vet Microbiol. 2006, 116: 249-257. 10.1016/j.vetmic.2006.05.002.View ArticlePubMed
- Wang L, Raidal SL, Pizzirani A, Wilcox GE: Detection of respiratory herpesviruses in foals and adult horses determined by nested multiplex PCR. Vet Microbiol. 2007, 121: 18-28. 10.1016/j.vetmic.2006.11.009.View ArticlePubMed
- Fortier G, van Erck E, Fortier C, Richard E, Pottier D, Pronost S, Miszczak F, Thiry E, Lekeux P: Herpesviruses in respiratory liquids of horses: Putative implication in airway inflammation and association with cytological features. Vet Microbiol. 2009, 139: 34-41. 10.1016/j.vetmic.2009.04.021.View ArticlePubMed
- Kleiboeker SB, Schommer SK, Johnson PJ, Ehlers B, Turnquist SE, Boucher M, Kreeger JM: Association of two newly recognized herpesviruses with interstitial pneumonia in donkeys (Equus asinus). J Vet Diagn Investig. 2002, 14: 273-280. 10.1177/104063870201400401.View Article
- Fortier G, Pronost S, Miszczak F, Fortier C, Leon A, Richard E, Van Erck E, Thiry E, Lekeux P: Identification of equid herpesvirus-5 in respiratory liquids: A retrospective study of 785 samples taken in 2006–2007. Vet J. 2009, 182: 346-348. 10.1016/j.tvjl.2008.07.004.View ArticlePubMed
- Williams KJ, Maes R, Del Piero F, Lim A, Wise A, Bolin DC, Caswell J, Jackson C, Robinson NE, Derksen F: Equine multinodular pulmonary fibrosis: A newly recognized herpesvirus-associated fibrotic lung disease. Vet Pathol. 2007, 44: 849-862. 10.1354/vp.44-6-849.View ArticlePubMed
- Wong DM, Belgrave RL, Williams KJ, Del Piero F, Alcott CJ, Bolin SR, Marr CM, Nolen-Walston R, Myers RK, Wilkins PA: Multinodular pulmonary fibrosis in five horses. Javma-Journal of the American Veterinary Medical Association. 2008, 232: 898-905. 10.2460/javma.232.6.898.View Article
- Williams K, Maes R, Bolin S: Multinodular pulmonary fibrosis and EHV-5 associated disease. Pferdeheilkunde. 2009, 25: 598-
- Mora AL, Woods CR, Garcia A, Xu JG, Rojas M, Speck SH, Roman J, Brigham KL, Stecenko AA: Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2005, 289: L711-L721. 10.1152/ajplung.00007.2005.View ArticlePubMed
- Hart KA, Barton MH, Williams KJ, Flaminio MJBF, Howerth EW: Multinodular pulmonary fibrosis, pancytopenia and equine herpesvirus-5 infection in a Thoroughbred gelding. Equine Veterinary Education. 2008, 20: 470-476.
- Poth T, Niedermaier G, Hermanns W: Equine Multinodular Pulmonary Fibrosis in association with an EHV-5 infection in 5 horses. Wiener Tierarztliche Monatsschrift. 2009, 96: 203-208.
- Niedermaier G, Poth T, Gehlen H: Clinical aspects of multinodular pulmonary fibrosis in two warmblood horses. Vet Rec. 2010, 166: 426-430. 10.1136/vr.b4811.View ArticlePubMed
- Soare T, Leeming G, Morgan R, Papoula-Pereira R, Kipar A, Stewart J, Hetzel U: Equine multinodular pulmonary fibrosis in horses in the UK. Vet Rec. 2011, 169: 313-View ArticlePubMed
- VanDevanter DR, Warrener P, Bennett L, Schultz ER, Coulter S, Garber RL, Rose TM: Detection and analysis of diverse herpes-viral species by consensus primer PCR. J Clin Microbiol. 1996, 34: 1666-1671.PubMed CentralPubMed
- Ehlers B, Borchers K, Grund C, Frolich K, Ludwig H, Buhk HJ: Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes. 1999, 18: 211-220. 10.1023/A:1008064118057.View ArticlePubMed
- Vengust M, Wen X, Bienzle D: Herpesvirus-associated neurological disease in a donkey. J Vet Diagn Investig. 2008, 20: 820-823. 10.1177/104063870802000620.View Article
- Huson DH, Bryant D: Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006, 23: 254-267.View ArticlePubMed
- Donaldson MT, Beech J, Ennulat D, Hamir AN: Interstitial pneumonia and pulmonary fibrosis in a horse. Equine Veterinary Journal. 1998, 30: 173-175. 10.1111/j.2042-3306.1998.tb04480.x.View ArticlePubMed
- Wilkins PA: Interstitial pneumonia. Current Therapy in Equine Medicine. Edited by: Robinson NE, Saunders WB. 2003, 425-429. 5View Article
- Vannella KM, Moore BB: Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair. 2008, 1: 2-10.1186/1755-1536-1-2.PubMed CentralView ArticlePubMed
- Vannella KM, Luckhardt TR, Wilke CA, van Dyk LF, Toews GB, Moore BB: Latent Herpesvirus Infection Augments Experimental Pulmonary Fibrosis. Am J Respir Crit Care Med. 2010, 181: 465-477. 10.1164/rccm.200905-0798OC.PubMed CentralView ArticlePubMed
- McMillan TR, Moore BB, Weinberg JB, Vannella KM, Fieldsl WB, Christensen PJ, Van Dyk LF, Toewsl GB: Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med. 2008, 177: 771-780. 10.1164/rccm.200708-1184OC.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.